Lotta Lundgren

1.1k total citations
15 papers, 440 citations indexed

About

Lotta Lundgren is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lotta Lundgren has authored 15 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Lotta Lundgren's work include Melanoma and MAPK Pathways (8 papers), Cutaneous Melanoma Detection and Management (6 papers) and Cancer Genomics and Diagnostics (4 papers). Lotta Lundgren is often cited by papers focused on Melanoma and MAPK Pathways (8 papers), Cutaneous Melanoma Detection and Management (6 papers) and Cancer Genomics and Diagnostics (4 papers). Lotta Lundgren collaborates with scholars based in Sweden, Japan and Poland. Lotta Lundgren's co-authors include Christian Ingvar, Håkan Olsson, Katja Harbst, Pär‐Ola Bendahl, Göran Jönsson, Henrik Ekedahl, Helena Cirenajwis, Anna-Maria Larsson, Ana Carneiro and Kristina Aaltonen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Lotta Lundgren

15 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lotta Lundgren Sweden	10	264	253	115	78	47	15	440
Veronica Höiom Sweden	15	416 1.6×	347 1.4×	162 1.4×	115 1.5×	77 1.6×	34	656
Yihua Qiu United States	7	144 0.5×	523 2.1×	95 0.8×	59 0.8×	25 0.5×	9	657
Kelly L. Slocum United States	7	121 0.5×	405 1.6×	194 1.7×	53 0.7×	44 0.9×	10	560
Elizabeth S. Litman United States	8	155 0.6×	512 2.0×	83 0.7×	105 1.3×	104 2.2×	9	755
Chi-Chao Chen United States	8	152 0.6×	267 1.1×	77 0.7×	124 1.6×	15 0.3×	11	482
Angelo Gámez‐Pozo Spain	15	169 0.6×	427 1.7×	257 2.2×	48 0.6×	45 1.0×	51	718
Javier Rangel United States	9	199 0.8×	348 1.4×	61 0.5×	67 0.9×	23 0.5×	14	478
Jingyin Yue United States	13	169 0.6×	597 2.4×	97 0.8×	58 0.7×	127 2.7×	20	737
Bárbara Fontanals-Cirera United States	7	151 0.6×	804 3.2×	88 0.8×	176 2.3×	38 0.8×	8	888
Camilla Avivi Israel	5	218 0.8×	242 1.0×	138 1.2×	68 0.9×	32 0.7×	6	409

Countries citing papers authored by Lotta Lundgren

Since Specialization

Citations

This map shows the geographic impact of Lotta Lundgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lotta Lundgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lotta Lundgren more than expected).

Fields of papers citing papers by Lotta Lundgren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lotta Lundgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lotta Lundgren. The network helps show where Lotta Lundgren may publish in the future.

Co-authorship network of co-authors of Lotta Lundgren

This figure shows the co-authorship network connecting the top 25 collaborators of Lotta Lundgren. A scholar is included among the top collaborators of Lotta Lundgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lotta Lundgren. Lotta Lundgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Kim, Yonghyo, Jeovanis Gil, Indira Plá, et al.. (2020). Protein Expression in Metastatic Melanoma and the Link to Disease Presentation in a Range of Tumor Phenotypes. Cancers. 12(3). 767–767. 2 indexed citations

Larsson, Anna-Maria, Sara Jansson, Pär‐Ola Bendahl, et al.. (2018). Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial. Breast Cancer Research. 20(1). 48–48. 91 indexed citations

Joensuu, Heikki, Jennifer A. Fraser, Hans Wildiers, et al.. (2018). Abstract GS3-04: A randomized phase III study of adjuvant trastuzumab for a duration of 9 weeks versus 1 year, combined with adjuvant taxane-anthracycline chemotherapy, for early HER2-positive breast cancer (the SOLD study). Cancer Research. 78(4_Supplement). GS3–4. 9 indexed citations

Welinder, Charlotte, Krzysztof Pawłowski, Attila Marcell Szász, et al.. (2017). Correlation of histopathologic characteristics to protein expression and function in malignant melanoma. PLoS ONE. 12(4). e0176167–e0176167. 20 indexed citations

Welinder, Charlotte, Krzysztof Pawłowski, Yutaka Sugihara, et al.. (2015). A Protein Deep Sequencing Evaluation of Metastatic Melanoma Tissues. PLoS ONE. 10(4). e0123661–e0123661. 15 indexed citations

Bagge, Roger Olofsson, Lars Ny, Malin Sternby Eilard, et al.. (2014). Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial. Trials. 15(1). 317–317. 29 indexed citations

Welinder, Charlotte, Göran Jönsson, Christian Ingvar, et al.. (2014). Analysis of Alpha-Synuclein in Malignant Melanoma – Development of a SRM Quantification Assay. PLoS ONE. 9(10). e110804–e110804. 19 indexed citations

Welinder, Charlotte, Göran Jönsson, Christian Ingvar, et al.. (2014). Feasibility Study on Measuring Selected Proteins in Malignant Melanoma Tissue by SRM Quantification. Journal of Proteome Research. 13(3). 1315–1326. 8 indexed citations

Sugihara, Yutaka, Ákos Végvári, Charlotte Welinder, et al.. (2014). A new look at drugs targeting malignant melanoma—An application for mass spectrometry imaging. PROTEOMICS. 14(17-18). 1963–1970. 23 indexed citations

10.

Harbst, Katja, Martin Lauss, Helena Cirenajwis, et al.. (2014). Molecular and genetic diversity in the metastatic process of melanoma. The Journal of Pathology. 233(1). 39–50. 48 indexed citations

11.

Welinder, Charlotte, Göran Jönsson, Christian Ingvar, et al.. (2013). Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinical capability. SHILAP Revista de lepidopterología. 2(1). 7–7. 12 indexed citations

12.

Ekedahl, Henrik, Helena Cirenajwis, Katja Harbst, et al.. (2013). The clinical significance ofBRAFandNRASmutations in a clinic-based metastatic melanoma cohort. British Journal of Dermatology. 169(5). 1049–1055. 89 indexed citations

13.

Harbst, Katja, Johan Staaf, Martin Lauss, et al.. (2012). Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma. Clinical Cancer Research. 18(15). 4026–4036. 72 indexed citations

14.

Lindén, Ola, Mats Ehinger, Sara Kinhult, et al.. (2012). Cetuximab and EGFR inhibitors in patients with neurological symptoms due to chordoma.. Journal of Clinical Oncology. 30(15_suppl). 10024–10024. 1 indexed citations

15.

Baldetorp, Bo, Maria C. Johansson, Christian Ingvar, et al.. (2009). Analysis of protein expression in pure cell nuclei populations isolated from human breast cancer tissue by DNA flow cytometric sorting. Journal of Proteomics. 73(6). 1111–1116. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact